Esaote unveils new ultrasound unit

Article

Ultrasound developer Esaote, based in Genoa, Italy, introduced a new premium ultrasound device at the RSNA show. Technos is designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, and completes Esaote’s radiology and

Ultrasound developer Esaote, based in Genoa, Italy, introduced a new premium ultrasound device at the RSNA show. Technos is designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, and completes Esaote’s radiology and shared service markets product line. The unit carries a fully digital beamformer and proprietary microchip circuitry, as well as new probe technology that maximizes the lateral resolution of Technos’ wideband multifrequency transducers. Technos combines color Doppler and power Doppler technology, and runs on a Windows NT operating system.

In other Esaote news, the company celebrated the sale of its 500th dedicated MRI system, which it has achieved through sales of both Artoscan and E-Scan, an open-style, 0.2-tesla MRI scanner dedicated to orthopedic studies. E-Scan was cleared by the Food and Drug Administration in June (SCAN 6/23/99).

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.